It feels good to finally get this off my chest. I recently posted a one-star Google review of the psychiatrist who prescribed the antidepressant that left me with PSSD and ultimately turned my life into a nightmare. Honestly, one star feels like far too much compared to what I have lost.
I also believe that reporting these symptoms and raising awareness about PSSD is essential, but so is holding accountable the doctors whose ignorance and failure to keep up with scientific knowledge can have devastating consequences for their patients. Google reviews are among the very few ways we have to publicly expose these failures and make these doctors face their responsibilities. Sometimes, it feels like the only way to make them listen.
“Certainly, this psychiatrist possesses human qualities and provides attentive follow-up care. However, his shortcomings in pharmacology and his obvious failure to keep his knowledge up to date raise serious questions about his professional responsibility.
In 2018, when I initially consulted him for generalized anxiety disorder (GAD), he prescribed me an antidepressant without informing me of the risk of persistent adverse effects after discontinuation. I trusted him completely and took this medication to help me get through a particularly stressful period. I then stopped taking it four months later, once that period had passed, without imagining for a single moment the devastating consequences that would follow.
Yet the risks of persistent dysfunction following SSRI and SNRI discontinuation had already been documented in the scientific literature before the European Medicines Agency (EMA) officially acknowledged them in May 2019. These risks were therefore not unknown at the time of my prescription in 2018.
It is particularly concerning that this psychiatrist appears to have been unaware of these risks and never informed me about them. Faced with GAD, he prioritized prescribing the antidepressants he routinely prescribed, seemingly convinced of their safety and evidently underestimating their potential for iatrogenic harm, without any apparent genuine individualized assessment of the risk-benefit balance or serious consideration of alternative treatments. My condition could nevertheless have been addressed through psychotherapy, CBT, or, if medication had been necessary, other drug classes potentially associated with a more favorable iatrogenic risk profile.
Following discontinuation, I developed Post-SSRI Syndrom (PSS), characterized by extremely severe symptoms: genital anesthesia, complete loss of libido and orgasmic sensations, profound emotional blunting, anhedonia, the loss of my ability to experience love, pleasure, and emotions, as well as cognitive and sensory disturbances. I want to emphasize that these physical, sexual, and sensory symptoms had absolutely nothing to do with my original GAD and are not psychosomatic manifestations. These dysfunctions profoundly disrupted my psychological well-being and contributed to the development of major depressive disorder (MDD).
When I reported the persistence of these symptoms to this psychiatrist, he assured me that side effects were absolutely reversible, dismissing my concerns and making them seem illegitimate. Over the following seven years, none of the treatments I tried brought even the slightest improvement in my PSS ; several actually made my condition worse. I consider it profoundly irresponsible for a physician prescribing psychotropic medication not to remain rigorously informed about scientific evidence and pharmacovigilance warnings concerning the risks associated with these drugs.
Today, I am completely disabled. Seven years after that prescription, the consequences of this treatment have turned my life upside down and destroyed it. My sexuality, my emotions, my sensations, my independence, and an enormous part of my life have been taken away from me. These consequences are real, relentless, and devastating. I am living with the aftermath of a treatment I had trusted him to prescribe, without ever having been properly informed of the risks.”